CD44 and gastric cancer: Similarly, Watanabe et al. [14] described circulating cells with a EpCAM+CD44+ phenotype in GC patients, reporting a sensitivity of 92.3%, specificity of 100%, and AUC of 0.974, although specificity and AUC could be questionable because they enrolled only 12 healthy volunteers compared with 26 patients.